Claims for Patent: 9,205,052

Summary for Patent: 9,205,052

Title:	Sustained-release liposomal anesthetic compositions
Abstract:	The invention provides a method for obtaining local anesthetics encapsulated in liposomes, such as multi vesicular liposomes, with high encapsulation efficiency and slow release in vivo. When the encapsulated anesthetic is administered as a single intracutaneous dose, the duration of anesthesia and half-life of the drug at the local injection site is increased as compared to injection of unencapsulated anesthetic. The maximum tolerated dose of the encapsulated anesthetic is also markedly increased in the liposomal formulation over injection of unencapsulated anesthetic. These results show that the liposomal formulation of local anesthetic is useful for sustained local infiltration and nerve block anesthesia.
Inventor(s):	Kim; Sinil (La Jolla, CA), Kim; Taehee (Carlsbad, CA), Murdande; Sharad (Waterford, CT)
Assignee:	Pacira Pharmaceuticals, Inc. (San Diego, CA)
Application Number:	13/842,198
Patent Claims:	1. A method of providing local anesthesia to a subject in need thereof comprising identifying a patient in need of local anesthesia; and administering in a single dose a multivesicular liposome, said multivesicular liposome comprising a therapeutically effective amount of bupivacaine phosphate, wherein the multivesicular liposome comprises: bupivacaine phosphate; at least one amphipathic lipid; at least one neutral lipid lacking a hydrophilic head group; and optionally, cholesterol and/or a plant sterol. 2. The method of claim 1, wherein the single dose administration is intracutaneously, subcutaneously, or via nerve block.